Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report

Fig. 2

The chest X-ray (A1–A3) of the patient showed that the pulmonary exudative lesions improved after standard treatment and increased before the second cytokine storm. In the patient’s chest CT (B1–B4), we can see the absorption and evolution of pulmonary exudative lesions in patients with COVID-19; comparing February 20 and February 17, the pulmonary exudative lesions have no significant improvement. After the application of convalescent plasma, a small amount of exudative lesions was seen on the chest CT on February 24 (B3). On February 27, after the first application of umbilical cord mesenchymal stem cell therapy, pulmonary exudative lesions improved significantly (B4)

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512